We are the trusted partner to over 400 sports organizations, including many of the world’s largest leagues and federations ...
HN01, a pivotal Phase 2/3 trial of ficerafusp alfa in 1L R/M HNSCC Completed upsized initial public offering, raising approximately $362 million in gross proceeds, with full exercise of the ...